Your search for tocilizumab returned 84 results

Your search for tocilizumab returned 84 results

Sort Results:

Relevant Recent
Drug Monograph

ACTEMRA

Tocilizumab 20mg/mL (vial); soln for IV infusion after dilution; 162mg/0.9mL (prefilled syringe, autoinjector); soln for SC inj; both: preservative-free.
ACR/ARHP Annual Meeting 2013

BREVACTA: SC Tocilizumab + DMARD Show Lasting Efficacy Up to Week 48

At the 2013 ACR/ARHP Annual Meeting, study authors presented data on subcutaneous tocilizumab that demonstrated long-term efficacy, including sustained ACR response rate and reduced joint damage progression over 48 weeks.